EX-CELL-O GmbH

Data on cancer discussed by researchers at University of Navarra.
Cancer Weekly; 11/10/2009; 882 words; ...specific CD8(+) T cells," scientists in...CD8 beta(+) T-cell-dependent mechanism...increased CTL activity Ex vivo analyses to determine...draining lymph node cell type responsible for...revealed that CD11c(+) cells, most likely DC...induction," wrote O. Murillo and ...

Other News To Note.
BIOWORLD Today; 11/4/2009; 2345 words; o 4SC AG, of Martinsried...and ProQinase GmbH, of Freiburg...platform, including cell-based assays...pharmacological testing. o Aclara BioSciences...destroy cancer cells in bone marrow or blood ex vivo using Th9402...selectively kill cancer cells when exposed to light. o ...

Data from D.C.M. Ferreira et al provide new insights into pharmacological.(Report)
Cancer Weekly; 5/5/2009; 812 words; ...reconstruction of the primary O-2(center dot...production by the cells. In the first hour...each quinone induced cell death by apoptosis...quinones in living cells. Ferreira and colleagues...study in Chembiochem (Ex vivo Activities of...information, contact M.O.F. Goulart, ...

Patent No. 7,475,469 Issued on Jan. 13, Assigned to Ex-Cell-O, GKN Driveline International for Profiled Track Production Process (German Inventors)
US Fed News Service, Including US State News; 3/14/2009; 390 words; ...475,469 on Jan. 13. The patent has been assigned to Ex-Cell-O GmbH, Eislingen/Fils, Germany, and GKN Driveline International GmbH, Lohmar, Germany. According to the abstract released...

Antitumor activity of C-21 steroidal glycosides from Cynanchum auriculatum Royle ex Wight.(SHORT COMMUNICATION)(Report)
Phytomedicine: International Journal of Phytotherapy & Phytopharmacology; 11/1/2008; 3549 words; ...auriculatum Royle ex Wight were performed...6-dideoxy-3-O-methy-[beta...6-dideoxy-3-O-methy-[beta...C) 2008 Elsevier GmbH. All rights reserved...6-dideoxy-3-O-methy-[beta...Caudatin; Human tumor cell lines; Antitumor...inhibit the cancer cells both in vitro and...